✨ Your Portfolio is fetched and updated from zerodha.
Large Pharmaceuticals

Sun Pharmaceutical Industries Ltd.

SUNPHARMA

Market Cap
₹4,46,792 Cr.
P/E
38.92

Sun Pharmaceutical Industries Ltd.

  • Sun Pharma. Inds.
  • Torrent Pharma
  • Cipla
  • TJI Pharma

FAQs on Sun Pharmaceutical Industries Ltd. Shareprice

Sun Pharma. Inds. has given lower returns compared to its competitors.
Sun Pharma. Inds. has grown at ~23.51% over the last 3yrs while peers have grown at a median rate of 24.5%

Sun Pharma. Inds. is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Sun Pharma. Inds. is 38.92, while 3 year average PE is 42.07.
Also latest EV/EBITDA of Sun Pharma. Inds. is 25.96 while 3yr average is 24.87.

View FAQ's On Business

Growth Table

  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharma
  • Cipla

Balance Sheet

  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharma
  • Cipla

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharma
  • Cipla

Cash Flow

  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharma
  • Cipla

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharma
  • Cipla

Quarterly Results

  • Sun Pharmaceutical Industries Ltd.
  • Torrent Pharma
  • Cipla

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Sun Pharmaceutical Industries Ltd. Financials

Balance sheet of Sun Pharma. Inds. is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Sun Pharma. Inds. is increasing.
Latest net debt of Sun Pharma. Inds. is -₹7,521.47 Crs as of Mar-26.
This is greater than Mar-25 when it was -₹20,721.2 Crs.

Yes, profit is increasing.
The profit of Sun Pharma. Inds. is ₹11,565 Crs for TTM, ₹10,929 Crs for Mar 2025 and ₹9,576 Crs for Mar 2024.

The company seems to pay a good stable dividend.
Sun Pharma. Inds. latest dividend payout ratio is 35.13% and 3yr average dividend payout ratio is 33.84%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech